However, osteogenic drugs such as parathyroid hormone injections, which activate Wnt signaling by downregulating sclerostin, are suspected of increasing the risk of osteosarcoma due to the excessive bone formation caused by their long duration of treatment in animal experiments [35,36]. Here, SOST is linked to osteosarcoma.